Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Kenvue Inc. Common Stock (NY:KVUE)

17.01 -0.01 (-0.06%)
Official Closing Price Updated: 6:30 PM EST, Dec 22, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Kenvue Inc. Common Stock

< Previous 1 2
...
7 8 9 10 11 12 13 14 15
...
25 26 Next >
News headline image
All It Takes Is $1,000 Invested in Each of These 3 Dividend Kings to Help Generate Over $100 in Passive Income Per Year ↗
Target, PepsiCo, and Kenvue have high yields and inexpensive valuations. 
Via The Motley Fool
News headline image
Navigating 10 Analyst Ratings For Kenvue ↗
 
Via Benzinga
News headline image
World's Third-Largest OTC Player Sanofi's Consumer Health Unit Nears $16B Deal With Clayton Dubilier & Rice ↗
Sanofi is negotiating a potential sale of a 50% stake in its consumer health unit, Opella, to Clayton Dubilier & Rice. The deal, valued at $16.4 billion, could help Sanofi sharpen its focus on... 
Via Benzinga
News headline image
P/E Ratio Insights for Kenvue ↗
 
Via Benzinga
News headline image
There are signs that NYSE:KVUE may be ready to breakout. ↗
KENVUE INC is setting up nicely for a breakout. 
Via Chartmill
News headline image
Analyst Ratings For Kenvue ↗
 
Via Benzinga
News headline image
Decoding 5 Analyst Evaluations For Kenvue ↗
 
Via Benzinga
News headline image
Private Equity Firms Circle Sanofi's Consumer Health Business Amid Potential Spinoff ↗
Sanofi plans to spin off its consumer healthcare division, which could be valued at over $16.8 billion. Private equity firms are bidding for the unit, with the spinoff expected by Q4 2024. Banks... 
Via Benzinga
News headline image
Kenvue Drives Climate Action Strategy Forward
From Kenvue
Via Business Wire
News headline image
Kenvue Set To Pop Like A Tylenol Gelcap? Golden Cross Looms On Stock Chart ↗
Kenvue Inc., owner of major brands like Tylenol, is poised for a technical knockout with a Golden Cross pattern and legal win. 
Via Benzinga
Worried About a Stock Market Sell-Off? Consider Coca-Cola, Pepsi, and These 3 Safe Dividend Kings for Decades of Passive Income. ↗
Via The Motley Fool
News headline image
Magnificent 7 Miss Out, 2 Cybersecurity Stocks Stand Firm, Retailers Lag In Volatile August: Here Are The Top S&P 500 Gainers And Losers ↗
The equity market was volatile in August, with the weakness seen early in the month dissipating amid a rise in rate-cut bets. 
Via Benzinga
Topics Stocks
News headline image
Johnson & Johnson-Spin Off Kenvue Wins Lawsuit Over Pain Killer Tylenol 'Rapid Release' Gelcaps ↗
Kenvue defends against a consumer lawsuit alleging that its Tylenol "Rapid Release" gelcaps did not relieve pain faster than regular tablets. A federal judge ruled the claims were preempted by FDA... 
Via Benzinga
Topics Lawsuit
News headline image
Donald Trump Owns These 21 Dividend Kings. Should You? ↗
Some of Trump's Dividend Kings deserve a crown more than others. 
Via The Motley Fool
Topics Government
News headline image
Kenvue Announces Participation in the Barclays Global Consumer Staples Conference
From Kenvue
Via Business Wire
News headline image
A Big CEO Move, Big Buffett Buys, and More ↗
Motley Fool analysts talk over market news including earnings updates from Home Depot, Walmart, and Brinker. 
Via The Motley Fool
News headline image
3 High-Yield Dividend ETFs to Buy to Generate Passive Income ↗
ETFs offer a good way to own a diversified portfolio of income-producing equities. 
Via The Motley Fool
Topics ETFs
News headline image
Lock in Gains: 3 Dividend Stocks Poised to Boost Payouts Soon
These three stocks have a long history of increasing their dividends and are likely to benefit from sector rotation on expectations of lower interest rates 
Via MarketBeat
Topics Artificial Intelligence Economy
News headline image
7 Stable Dividend Stocks to Scoop Up on Discount ↗
The market is looking shaky. To help calm your nerves and sleep easier at night, consider adding these stable dividend stocks to your holdings. 
Via InvestorPlace
News headline image
Shopify, Palantir And Uber Are Among Top 10 Large Cap Gainers Last Week (Aug 4-Aug 10): Are The Others In Your Portfolio? ↗
Top 10 best performing large-cap stocks last week: Shopify, Palantir, Axon, Fortinet, Trade Desk, Natera, SharkNinja, Zillow, Aspen Tech, Uber. 
Via Benzinga
News headline image
2 Healthcare Stocks to Buy Hand Over Fist in August ↗
These longtime winners still have a lot to offer. 
Via The Motley Fool
News headline image
The Defensive Sectors And VIX Have NOT Given The All-Clear Signal ↗
The market has been a rollercoaster lately, with the resilience of defensive sectors and the modest bounce in the technology sector painting an intriguing picture. 
Via Talk Markets
Topics Stocks
News headline image
The 7 Best Under $20 Stocks to Buy in August 2024 ↗
Although cheap stocks are often cheap for a reason, it doesn't hold true for the best stocks under $20, which is where investors can profit. 
Via InvestorPlace
News headline image
Kenvue (KVUE) Q2 2024 Earnings Call Transcript ↗
KVUE earnings call for the period ending June 30, 2024. 
Via The Motley Fool
Topics Earnings
News headline image
Kenvue News: Why Investors Are Loving KVUE Stock This Week ↗
Kenvue investors are seeing a nice 14% pop in KVUE stock today, after the company reported second quarter earnings that beat on both lines. 
Via InvestorPlace
News headline image
Yum China Posts Upbeat Earnings, Joins Clear Secure, TG Therapeutics, Bioventus And Other Big Stocks Moving Higher On Tuesday ↗
 
Via Benzinga
News headline image
KVUE Stock Earnings: Kenvue Beats EPS, Beats Revenue for Q2 2024 ↗
KVUE stock results show that Kenvue beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
Via InvestorPlace
News headline image
Listerine-Maker Kenvue's Stock Soars On Strong Q2 Sales From Its Essential Health Unit, Reaffirms Annual Guidance ↗
Kenvue sees stock rise following strong Q2 2024 results. Despite a slight dip in sales, revenue of $4 billion beat expectations. The company's iconic brands and strategic price actions contributed to... 
Via Benzinga
News headline image
Kenvue Reports Second Quarter 2024 Results
From Kenvue
Via Business Wire
News headline image
All It Takes Is $10,000 Invested in Coca-Cola and Each of These 2 Dividend Kings to Generate Over $1,000 in Passive Income per Year ↗
Constructing a portfolio that is built to last requires investing in quality companies, purposeful allocation, and diversification. 
Via The Motley Fool
< Previous 1 2
...
7 8 9 10 11 12 13 14 15
...
25 26 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.